266 related articles for article (PubMed ID: 25468168)
1. Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials.
; Ying A; Arima H; Czernichow S; Woodward M; Huxley R; Turnbull F; Perkovic V; Neal B
Lancet; 2015 Mar; 385(9971):867-74. PubMed ID: 25468168
[TBL] [Abstract][Full Text] [Related]
2. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
Ettehad D; Emdin CA; Kiran A; Anderson SG; Callender T; Emberson J; Chalmers J; Rodgers A; Rahimi K
Lancet; 2016 Mar; 387(10022):957-967. PubMed ID: 26724178
[TBL] [Abstract][Full Text] [Related]
4. Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.
Weber MA; Jamerson K; Bakris GL; Weir MR; Zappe D; Zhang Y; Dahlof B; Velazquez EJ; Pitt B
Lancet; 2013 Feb; 381(9866):537-45. PubMed ID: 23219284
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal.
Zanchetti A; Thomopoulos C; Parati G
Circ Res; 2015 Mar; 116(6):1058-73. PubMed ID: 25767290
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular protection and blood pressure reduction: a meta-analysis.
Staessen JA; Wang JG; Thijs L
Lancet; 2001 Oct; 358(9290):1305-15. PubMed ID: 11684211
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.
Blood Pressure Lowering Treatment Trialists' Collaboration
Lancet; 2021 May; 397(10285):1625-1636. PubMed ID: 33933205
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.
Pinho-Gomes AC; Azevedo L; Copland E; Canoy D; Nazarzadeh M; Ramakrishnan R; Berge E; Sundström J; Kotecha D; Woodward M; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K;
PLoS Med; 2021 Jun; 18(6):e1003599. PubMed ID: 34061831
[TBL] [Abstract][Full Text] [Related]
9. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.
Neal B; MacMahon S; Chapman N;
Lancet; 2000 Dec; 356(9246):1955-64. PubMed ID: 11130523
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.
Nazarzadeh M; Bidel Z; Canoy D; Copland E; Bennett DA; Dehghan A; Davey Smith G; Holman RR; Woodward M; Gupta A; Adler AI; Wamil M; Sattar N; Cushman WC; McManus RJ; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K;
Lancet Diabetes Endocrinol; 2022 Sep; 10(9):645-654. PubMed ID: 35878651
[TBL] [Abstract][Full Text] [Related]
11. The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials.
Czernichow S; Zanchetti A; Turnbull F; Barzi F; Ninomiya T; Kengne AP; Lambers Heerspink HJ; Perkovic V; Huxley R; Arima H; Patel A; Chalmers J; Woodward M; MacMahon S; Neal B;
J Hypertens; 2011 Jan; 29(1):4-16. PubMed ID: 20881867
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
Leenen FH
Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
[TBL] [Abstract][Full Text] [Related]
13. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials.
Pahor M; Psaty BM; Alderman MH; Applegate WB; Williamson JD; Cavazzini C; Furberg CD
Lancet; 2000 Dec; 356(9246):1949-54. PubMed ID: 11130522
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.
; Ninomiya T; Perkovic V; Turnbull F; Neal B; Barzi F; Cass A; Baigent C; Chalmers J; Li N; Woodward M; MacMahon S
BMJ; 2013 Oct; 347():f5680. PubMed ID: 24092942
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
16. Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatients.
Bhan V; Yan RT; Leiter LA; Fitchett DH; Langer A; Lonn E; Tan M; Silagy S; Goodman SG; Yan AT;
Am J Cardiol; 2010 Nov; 106(9):1270-6. PubMed ID: 21029823
[TBL] [Abstract][Full Text] [Related]
17. Effects of different blood-pressure-lowering regimens on major cardiac events.
Steffen HM; Toex U; Kolloch R
Lancet; 2004 Jan; 363(9405):331; author reply 331-2. PubMed ID: 14751718
[No Abstract] [Full Text] [Related]
18. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials.
Turnbull F; Woodward M; Neal B; Barzi F; Ninomiya T; Chalmers J; Perkovic V; Li N; MacMahon S;
Eur Heart J; 2008 Nov; 29(21):2669-80. PubMed ID: 18852183
[TBL] [Abstract][Full Text] [Related]
19. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.
Turnbull F; Neal B; Algert C; Chalmers J; Chapman N; Cutler J; Woodward M; MacMahon S;
Arch Intern Med; 2005 Jun; 165(12):1410-9. PubMed ID: 15983291
[TBL] [Abstract][Full Text] [Related]
20. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
